EC Number   |
Disease   |
PubMed ID   |
Title of Publication   |
Category |
Confidence Level |
|---|
 2.4.1.244 | Colonic Neoplasms |
17579116 |
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. |
causal interaction |
4 |
 2.4.1.244 | Colonic Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
causal interaction |
4 |
 2.4.1.244 | Colonic Neoplasms |
17395692 |
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. |
diagnostic usage |
3 |
 2.4.1.244 | Colonic Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
diagnostic usage |
4 |
 2.4.1.244 | Colonic Neoplasms |
17395692 |
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. |
therapeutic application |
1 |
 2.4.1.244 | Colonic Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
therapeutic application |
2 |
 2.4.1.244 | Colonic Neoplasms |
17579116 |
Beta1,4-N-acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. |
ongoing research |
4 |
 2.4.1.244 | Colonic Neoplasms |
17395692 |
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. |
ongoing research |
3 |
 2.4.1.244 | Colonic Neoplasms |
25003232 |
?1, 4-N-acetylgalactosaminyltransferase III modulates cancer stemness through EGFR signaling pathway in colon cancer cells. |
ongoing research |
3 |
 2.4.1.244 | Colonic Neoplasms |
17395692 |
Biosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon. |
unassigned |
0 |